Review article: Alternative antibacterial agents for Helicobacter pylori eradication

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 10, 2001, Pages 1543-1547

  Guslandi, M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BISMUTH; BISMUTH CITRATE; BISMUTH NITRATE; CLARITHROMYCIN; FAMOTIDINE; FURAZOLIDONE; JOSAMYCIN; LANSOPRAZOLE; LEVOFLOXACIN; MACROLIDE; METRONIDAZOLE; NITROFURAN DERIVATIVE; NORFLOXACIN; OMEPRAZOLE; PEFLOXACIN; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RABEPRAZOLE; RANITIDINE; RANITIDINE BISMUTH CITRATE; RIFABUTIN; ROXITHROMYCIN; SECNIDAZOLE; SPIRAMYCIN; TETRACYCLINE DERIVATIVE; TINIDAZOLE; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; GASTRITIS; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; REVIEW; STOMACH ULCER;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MYCOBACTERIUM AVIUM; NITROFURANS; RIFABUTIN;

EID: 0034789301     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01064.x     Document Type: Review

References (37)

1. Treatment of Helicobacter pylori infection in humans; a review of the world literature
2. Treatment after failure: The problem of 'non-responders'
3. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
4. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice
5. Seven-day rescue therapy after Helicobacter pylori treatment failure: Omeprazole. bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole
6. Third line treatment for Helicobacter pylori: A prospective, culture-guided study in peptic ulcer patients
7. A new quadruple therapy for Helicobacter pylori: Influence of resistant strains on treatment outcome
8. Eradication of Helicobacter pylori with lansoprazole, roxithromycin and metronidazole - An open pilot study
9. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: A randomized controlled trial
10. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate. Furazolidone and clarithromycin triple therapy for 1 week
11. A new quadruple therapy for Helicobacter pylori using tripotassium dicitrato bismuthate, furazolidone, josamycin and famotidine
12. Azithromycin levels in plasma and gastric tissue, juice and mucus
13. Pantoprazole, azithromycin and tinidazole: Short duration triple therapy for eradication of Helicobacter pylori infection
14. Triple therapy with azithromycin, omeprazole and amoxycillin is highly effective in the eradication of Helicobacter pylori: A controlled trial versus omeprazole plus amoxycillin
15. Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori
16. Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease
17. Azithromycin triple therapy for Helicobacter pylori infection: Azithromycin, tetracycline and bismuth
18. Spiramycin in triple therapy of Helicobacter pylori-associated peptic ulcer disease. An open pilot study with 12-month follow-up
19. Spyramicin is comparable to oxytetracycline in eradicating H. pylori when given with ranitidine bismuth citrate and metronidazole
20. Eradication of H. pylori in a developing country: Comparison of lansoprazole versus omeprazole with norfloxacin in a dual-therapy study
21. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country
22. Efficacy of two one-week omeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection
23. Simple noninvasive method to test efficacy of drugs in the eradication of Helicobacter pylori infection: The example of combined bismuth subsalicylate and nitrofurantoin
24. Nitrofurantoin quadruple therapy for Helicobacter pylori infection: Effect of metronidazole resistance
25. Low cure rate of Helicobacter pylori infection with omeprazole and furazolidone dual therapy for one week
26. Antimicrobial treatment of Helicobacter pylori infection
27. Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infection
28. Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection
29. Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer
30. A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China
31. Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease
32. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate
33. Furazolidone combination therapies for Helicobacter pylori infection in the United States
34. A randomized study of two 'rescue' therapies for Helicobacter pylori-infected patients after failure of standard triple therapies
35. Comparative efficacy of new investigational agents against Helicobacter pylori
36. In vitro activities of ABT-773, a new ketolide, alone and in combination with amoxicillin, metronidazole or tetracycline against Helicobacter pylori
37. Susceptibility of Helicobacter pylori to mupirocin, oxazolidones, quinopristin/dalfopristin and new quinolones